Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Schizochytrium oil is a rich, vegetarian source of long-chain omega-3 fatty acids, particularly docosahexaenoic acid (DHA) and, to a lesser extent, eicosapentaenoic acid (EPA). The use of omega-3 fatty acids for cardiovascular health is well supported by scientific evidence, particularly in the context of reducing triglyceride levels, lowering blood pressure modestly, and supporting overall heart health. Most of the foundational cardiovascular studies have focused on fish oil, but Schizochytrium oil, as an algal-derived source of DHA, has been shown in several clinical trials to increase blood levels of DHA and provide similar lipid-modulating effects.

Specifically, randomized controlled trials have demonstrated that supplementation with Schizochytrium oil can lower triglyceride levels and, in some cases, modestly increase HDL cholesterol. A 2018 meta-analysis of algal oil (including Schizochytrium oil) found comparable effects to fish oil in improving omega-3 status and cardiovascular risk markers. However, large-scale outcome trials specifically targeting hard cardiovascular endpoints (such as myocardial infarction or mortality) using Schizochytrium oil are limited, and most recommendations are extrapolated from general omega-3 research.

Overall, the scientific rationale for using Schizochytrium oil to support cardiovascular health is based on its omega-3 content, with moderate evidence supporting benefits for lipid parameters. Direct evidence for major cardiovascular outcomes is still emerging, so the evidence rating reflects this moderate certainty.

More about Schizochytrium Oil
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Schizochytrium Oil

Products containing Schizochytrium Oil